Health Dictionary Find a Doctor

Metabolic acidosis

For patient information page, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, M.D. [2]

Synonyms and keywords: Acidosis, metabolic

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In medicine, metabolic acidosis is an acid-base imbalance in which the blood pH is low (less than 7.35) due to increased production of H+ by the body or the inability of the body to form bicarbonate (HCO3) in the kidney. Its causes are diverse, and its consequences can be serious, including diarrhea, coma and death. Together with respiratory acidosis, it is one of the two general types of acidosis, the other being respiratory acidosis.

Treatment

Medical Therapy

A pH under 7.1 is an emergency, due to the risk of cardiac arrhythmias, and may warrant treatment with intravenous bicarbonate. Bicarbonate is given at 50-100 mmol at a time under scrupulous monitoring of the arterial blood gas readings. This intervention however, is not effective in case of lactic acidosis. If the acidosis is particularly severe and/or there may be intoxication, consultation with the nephrology team is considered useful, as dialysis may clear both the intoxication and the acidosis.

References

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Classification

Metabolic acidosis can be classified as:

  • Low anion gap metabolic acidosis
  • Normal anion gap metabolic acidosis (Hyperchloremic Acidosis)
  • High anion gap metabolic acidosis

Normal Anion Gap (Hyperchloremic Acidosis)

Usually the HCO3 lost is replaced by a chloride anion, and thus there is a normal anion gap. In normal anion gap acidosis, the increased anion is chloride, which is measured, so the anion gap does not increase. Thus, normal anion gap acidosis is also known as hyperchloremic acidosis. Urine anion gap is useful in evaluating a patient with a normal anion gap.

Coexistent Elevated Anion Gap and Normal Anion Gap Metabolic Acidosis

  • An elevated anion gap can coexist with a normal anion gap metabolic acidosis.
  • In a single acid-base disorder of elevated anion gap metabolic acidosis, serum bicarbonate (HCO3) will decrease by the same amount that the anion gap increases.
  • However, a situation in which the anion gap increases less and serum bicarbonate decreases significantly indicates that there is another metabolic acidosis present, which is decreasing the the serum bicarbonate, but not affecting the anion gap i.e. normal anion gap metabolic acidosis is also present.
  • Thus, it is advised to compare the changes in the anion gap with the changes in the serum bicarbonate.
  • This is often referred as the delta-delta equation, or the corrected bicarbonate equation.
  • Delta-Delta equation: Change in anion gap = Change in bicarbonate

References

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

Metabolic acidosis is the state of low blood pH that can result from:

  • Failure of the kidneys to excrete H+
  • Increased H+ load
  • Loss of bicarbonate

Shown below is a table summarizing the mechanisms of metabolic acidosis.

Mechanism Conditions
Failure to excrete H+

Decreased production of NH4+:

  • Renal failure
  • Renal tubular acidosis type 4 (hypoaldosteronism)

Decreased secretion of H+

  • Renal tubular acidosis type 1
Increased H+ load
  • Lactic acidosis
  • Ketoacidosis
  • Ingestions
  • Massive rhabdomyolysis
Loss of bicarbonate

Gastrointestinal loss of bicarbonates:

  • Diarrhea
  • Cholestyramine

Renal loss of bicarbonate:

  • Renal tubular acidosis type 2
  • Diuretics such as carbonic anhydrase inhibitors)

High Anion Gap Metabolic Acidosis

High anion gap metabolic acidosis can be caused by one of the following:

  • Lactic acidodis
  • Ketoacidosis
  • Renal failure
  • Ingestions

Lactic Acidosis

Ketoacidosis

Renal Failure

Ingestions

Compensatory Mechanisms

Metabolic acidosis is either due to increased generation of acid or an inability to generate sufficient bicarbonate. The body regulates the acidity of the blood by four buffering mechanisms.

Respiratory Compensation of Metabolic Acidosis

  • For 1 meq/L fall of serum HCO3 levels there is a 1.2 mmHg fall in arterial pCO2.
  • The respiratory compensation of metabolic acidosis is fast and begins within half an hour of metabolic acidosis.
  • In cases where the metabolic acidosis develops slowly, the respiratory compensation occurs simultaneously with the metabolic acidosis.
  • The respiratory compensation usually completes within 12 to 24 hours
  • A failure to develop adequate respiratory response indicates an acute underlying respiratory disease, neurologic disease or a very acute development of metabolic acidosis.
  • Formula for checking appropriate respiratory compensation to metabolic acidosis include:
    • Arterial pCO2 = 1.5 x serum HCO3 + 8 ± 2 (Winters’ formula)
    • Arterial pCO2 = Serum HCO3 + 15

Role of the Urine Anion Gap in the Patient with a Normal Anion Gap Metabolic Acidosis

  • A urine anion gap helps to differentiate renal tubular acidosis (specifically a Type 1 or Type 4 RTA) from other causes of normal anion gap acidosis.
  • The urine anion gap is calculated as the urine sodium plus urine potassium, minus the urine chloride
  • Urine anion gap = (Urine Na + Urine K) – Urine Cl
  • The pathophysiology behind this is:
    • When the kidney is exposed to acidosis, the normal response of the kidney is to excrete acid.
    • Kidney excretes the excess acid in the form of ammonium, NH4+.
    • To maintain neutrality, Cl- is excreted along with ammonium, NH4+.
    • Thus, urine chloride acts as a surrogate marker for urine ammonium (acidosis)
    • In Types 1 and 4 renal tubular acidosis, the kidney’s function of acid excretion is compromised (decreased excretion of NH4+ and Cl).
    • Thus, in renal tubular acidosis (specifically a Type 1 or Type 4 RTA) urine anion gap will be high (> than zero).
    • A urine anion gap less than zero in the normal anion gap metabolic acidosis suggests the kidney is excreting acid, making renal tubular acidosis less likely.

Role of Osmolar Gap in Differential Diagnosis of Elevated Anion Gap

  • Methanol, ethylene glycol, isopropyl alcohol, toluene are osmotically active substances.
  • The estimated serum osmolality should be close to the actual, measured serum osmolality (within 10 points).
  • If the measured serum osmolality is much higher (i.e. >10 points) than the estimated serum osmolality then presence of osmotically active substances should be suspected.
  • They can be differentiated because of these following characteristics:
    • Methanol
    • Ethylene Glycol
      • Used in antifreeze and solvents
      • Presentation: Delirium
      • Elevated anion gap metabolic acidosis
      • Presence of oxalate crystals in urine
    • Isopropyl Alcohol
      • Also called rubbing alcohol
      • No acid-base disorder
      • Metabolism causes increase acetone in the blood
      • Other conditions with elevated acetones in blood are: diabetes, starvation, and isopropyl alcohol.
    • Toluene
      • Initial elevated anion gap followed with normal anion gap
  • Estimated serum osmolality = (2 * serum sodium + BUN/2.8 + Glucose/18)

Buffer

  • The decreased bicarbonate that distinguishes metabolic acidosis is therefore due to two separate processes: the buffer (from water and carbon dioxide) and additional renal generation. The buffer reactions are: :H+ + HCO3 <–> H2CO3 <–> CO2 + H2O
  • The Henderson-Hasselbalch equation mathematically describes the relationship between blood pH and the components of the bicarbonate buffering system:
pH=pKa + log [HCO3]/[CO2]
Using Henry’s Law, we can say that [CO2]=0.03xPaCO2
(PaCO2 is the pressure of CO2 in arterial blood)
Adding the other normal values, we get
pH = 6.1 + log (24/0.03×40)
= 6.1 + 1.3
= 7.4

References

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]

Overview

Metabolic acidosis is a state in which the blood pH is low (less than 7.35) due to an increased blood concentration of H+.

Causes

Life Threatening Causes

Common Causes

Normal Anion Gap (Hyperchloremic Acidosis)

The mnemonic for the most common causes of a normal-anion gap metabolic acidosis is “DURHAM.”

High Anion Gap

The mnemonic “MUDPILES” is used to remember the causes of a high anion gap.

Causes by Organ System

Cardiovascular Aortic arch interruption, Fanconi-Albertini-Zellweger syndrome, hypoplastic left heart syndrome, shock
Chemical / poisoning aldicarb, 4-aminopyridine, ammonium bifluoride, ammonium chloride, aristolochic acid , borates, bromophos, carbaryl, chloralose, chlorfenvinphos, chlorpyrifos, cleistanthus collinus, clove, coumaphos, cyanides, demeton-S-methyl, diazinon, 1,2-Dibromoethane, dichlorvos, dicrotophos, dinitrophenol, dioxathion, disulfoton, ethanol, ethion, ethylene glycol, fensulfothion, fenthion, glycol ether, glyphosate, imazapyr, iron compounds, iobenguane I 123,malathion, margosa oil, metaldehyde, methanol, methidathion, methiocarb, methomyl, monochloroacetate, parathion, phenol, phosdrin, polyethylene glycol , profenofos, propoxur, propylene glycol, pyrimidifen, salicylate poisoning, strychnine, terbufos, tetraethyl pyrophosphate, toluene, toxic mushrooms , triethylene glycol, tungsten
Dermatologic No underlying causes
Drug Side Effect Abacavir, Acetaminophen and Oxycodone, acetazolamide, amitriptyline, amlodipine, amoxapine, amphotericin B, aspirin, cholestyramine, clomipramine, clove, cocaine, desipramine, didanosine, doxepin, emtricitabine, felodipine , formoterol, imipramine, isoniazid, isradipine, Ixabepilone, Mafenide, malignant hyperpyrexia, malignant hyperthermia, metformin, neuroleptic malignant syndrome, nifedipine, nimodipine, nitroprusside, nortriptyline, Oxaliplatin, paracetamol, phenformin, Potassium chloride, protriptyline, Reye’s syndrome, salicylate poisoning, stavudine, topiramate, trimipramine
Ear Nose Throat No underlying causes
Endocrine Adrenal cortex insufficiency, 17- beta-hydroxysteroid dehydrogenase deficiency, diabetes, diabetic ketoacidosis, glucocorticoid resistance, hyperosmolar non-ketotic diabetic coma, hypoaldosteronism, lipoid congenital adrenal hyperplasia, pseudohypoaldosteronism, VIPoma
Environmental No underlying causes
Gastroenterologic Acute liver failure, bacterial overgrowth of small intestine, biliary fistula, congenital chloride diarrhea, diarrhea, duodenal atresia, GI HCO3- loss, hepatic failure, intestinal fistulas, intestinal ischaemia, lactose intolerance, necrotizing enterocolitis, pancreatic fistula, VIPoma
Genetic 17- beta-hydroxysteroid dehydrogenase deficiency, biotinidase deficiency, coenzyme Q10 deficiency, congenital chloride diarrhea, cystinosis, dihydrolipoamide dehydrogenase deficiency, fructose-1, 6-diphosphatase deficiency, ethylmalonic encephalopathy, Fanconi-Albertini-Zellweger syndrome, fructose-1-phosphate aldolase deficiency, galactosemia, glucose transporter type 1 deficiency, glutaric aciduria, glutathione synthetase deficiency, glycerol kinase deficiency, glycogenosis, GRACILE syndrome, Hawkinsinuria, hepatocerebral form of mitochondrial DNA depletion syndrome, HMG-CoA lyase deficiency, holocarboxylase synthase deficiency, 3-hydroxyacyl-coenzyme A dehydrogenase deficiency, 3 hydroxyisobutyric aciduria, isovaleric acidaemia, lipoid congenital adrenal hyperplasia, long chain hydroxyacyl-CoA dehydrogenase deficiency, Lowe syndrome, Lutz-Richner and Landolt syndrome, malignant hyperpyrexia, malignant hyperthermia, malonyl-CoA decarboxylase deficiency, maple syrup urine disease, medium chain acyl-CoA dehydrogenase deficiency, medullary cystic kidney disease, MELAS, MERRF, 3-methylcrotonyl-CoA carboxylase deficiency, 3-methylglutaconic aciduria, methylmalonic acidemia, microcephaly, Amish type, mitochondrial acetoacetyl-CoA thiolase deficiency, mitochondrial aspartyl-tRNA synthetase deficiency, molybdenum cofactor deficiency, myopathy with deficiency of succinate dehydrogenase and aconitase, nephronophthisis, osteopetrosis with renal tubular acidosis, phosphoglucomutase deficiency, propionic acidemia, propionyl-CoA carboxylase deficiency, pseudohypoaldosteronism, pyruvate carboxylase deficiency, pyruvate dehydrogenase deficiency, Senior-Loken syndrome, short-chain acyl-coenzyme A dehydrogenase deficiency, succinyl-CoA acetoacetate transferase deficiency, succinyl-CoA synthetase deficiency, vitamin B12-responsive methylmalonic acidemia
Hematologic Myeloma
Iatrogenic Hyperalimentation, malignant hyperpyrexia, malignant hyperthermia, Reye’s syndrome, short bowel syndrome, ureteral diversion, ureterosigmoidostomy
Infectious Disease No underlying causes
Musculoskeletal / Ortho Myopathy with deficiency of succinate dehydrogenase and aconitase, osteopetrosis with renal tubular acidosis
Neurologic Leigh syndrome, Lowe Syndrome, microcephaly, Amish type
Nutritional / Metabolic 17- beta-hydroxysteroid dehydrogenase deficiency, biotinidase deficiency, coenzyme Q10 deficiency, cystinosis, diabetic ketoacidosis, dihydrolipoamide dehydrogenase deficiency, fructose-1, 6-diphosphatase deficiency, ethylmalonic encephalopathy, Fanconi-Albertini-Zellweger syndrome, fructose-1-phosphate aldolase deficiency, galactosemia, glutaric aciduria, glutathione synthetase deficiency, glycerol kinase deficiency, glycogenosis, Hawkinsinuria, HMG-CoA lyase deficiency, holocarboxylase synthase deficiency, 3-hydroxyacyl-coenzyme A dehydrogenase deficiency, 3 hydroxyisobutyric aciduria, Hyperkalaemia, hyperosmolar non-ketotic diabetic coma, hypoalbuminism, isovaleric acidaemia, ketoacidosis, lactic acidosis, Leigh syndrome, long chain hydroxyacyl-CoA dehydrogenase deficiency, malonyl-CoA decarboxylase deficiency, maple syrup urine disease, medium chain acyl-CoA dehydrogenase deficiency, 3-methylcrotonyl-CoA carboxylase deficiency, 3-methylglutaconic aciduria, methylmalonic acidemia, mitochondrial acetoacetyl-CoA thiolase deficiency, molybdenum cofactor deficiency, myopathy with deficiency of succinate dehydrogenase and aconitase, organic acidemia, phosphoglucomutase deficiency, propionic acidemia, propionyl-CoA carboxylase deficiency, pyruvate carboxylase deficiency, pyruvate dehydrogenase deficiency, short-chain acyl-coenzyme A dehydrogenase deficiency, succinyl-CoA acetoacetate transferase deficiency, succinyl-CoA synthetase deficiency, vitamin B12-responsive methylmalonic acidemia
Obstetric/Gynecologic No underlying causes
Oncologic Myeloma
Opthalmologic Lowe syndrome, Senior-Loken syndrome
Overdose / Toxicity Abacavir, acetazolamide, amitriptyline, amlodipine, amoxapine, amphotericin B, aspirin, cholestyramine, clomipramine, clove, cocaine, desipramine, didanosine, doxepin, emtricitabine, felodipine , imipramine, isoniazid, isradipine, malignant hyperpyrexia, malignant hyperthermia, metformin, neuroleptic malignant syndrome, nifedipine, nimodipine, nitroprusside, nortriptyline, paracetamol, phenformin, protriptyline, Reye’s syndrome, salicylate poisoning, stavudine, trimipramine
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal / Electrolyte Acute renal failure, analgesic nephropathy syndrome, chronic interstitial nephritis, chronic renal failure, compensation in primary respiratory alkalosis, hypoaldosteronism, Lightwood Albright syndrome, Lowe syndrome, medullary cystic kidney disease, nephronophthisis, osteopetrosis with renal tubular acidosis, renal HCO3- loss, renal tubular acidosis, Senior-Loken syndrome, Ureteral diversion
Rheum / Immune / Allergy No underlying causes
Sexual 17- beta-hydroxysteroid dehydrogenase deficiency
Trauma No underlying causes
Urologic Ureteral diversion
Dental No underlying causes
Miscellaneous Cuffed blood sample, near-drowning, starvation

Causes in Alphabetical Order


References

Template:WH Template:WS

Differentiating Metabolic Acidosis from other Diseases


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Metabolic acidosis is occured in different situations such as poisoning, ketoacidosis, renal, gastrointestinal, cardiac, endocrine, and systemic diseases. 

Metabolic Acidosis Differential Diagnosis

Differential diagnosis of metabolic acidosis is as follow:[1][2][3][4]

To review differential diagnosis of high anion gap metabolic acidosis, click here.

To review differential diagnosis of high osmolar gap metabolic acidosis, click here.

To review differential diagnosis of metabolic acidosis and lactic acidosis, click here.

Category Disease Mechanism Clinical Paraclinical Gold standard diagnosis Other findings
Symptoms Signs Lab data
ABG CBC Chemistry Renal U/A
↑ acid
production
Loss of
bicarbonate
↓ renal acid
excretion
Fever N/V Diarrhea Dyspnea Toxic/ill BP Dehydration Level of consciousness HCO3 paCO2 O2 WBC Hb BS Cl K+ Na+ Ketones Lactic acid Serum AG[5] Osmolar gap[6] Bun Cr Urine pH Urine AG Urine ketone
Toxin/Medication[7] Alcohol poisoning[8][9] + + + ↓ ↑ + Nl Nl Nl + Nl or ↑ Nl or ↑ + + Clinical manifestation
+ + + + Nl Nl Nl Nl + Nl Nl Nl or ↑ + + Clinical manifestation
  • Not applicable
Toluene toxicity[11] + + + + ↓↓ Nl Nl Nl Nl Nl Nl Nl or ↑ Nl + Clinical manifestation
  • Most widely abused inhaled drugs
Salicylates overdose[12] + + + + + ↓↓ Nl Nl Nl to ↓ Nl Nl Clinical and elevated serum salicylate level
Metformin[13] + + + ± Agitated Nl Nl to ↑ Nl Nl Nl Nl Nl or ↑ Nl Clinical manifestation
Isoniazid[14] + + + + Agitated Nl Nl Nl Nl Nl Nl Nl Nl Nl or ↑ Nl Clinical manifestation
Acetazolamide[15] + + Nl Nl to ↓ Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl or ↑ Nl Clinical manifestation
  • Not applicable
Amphotericin B[16] + + + + + Nl to ↓ Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Clinical manifestation
  • Not applicable
Carbon monoxide poisoning[17] + + ± + Nl ↓↓ Nl to ↓ Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Clinical manifestation
  • Not applicable
Cyanide poisoning[18] + + + ± ↓↓ Nl to ↑ Nl Nl Nl Nl Nl Nl Nl or ↑ Nl Blood cyanide concentration
  • Not applicable
Category Disease ↑ acid
production
Loss of
bicarbonate
↓ renal acid
excretion
Fever N/V Diarrhea Dyspnea Toxic/ill BP Dehydration Level of consciousness HCO3 paCO2 O2 WBC Hb BS Cl K+ Na+ Ketones Lactic acid Serum AG Osmolar gap Bun Cr Urine pH Urine AG Urine ketone Gold standard diagnosis Other findings
Ketoacidosis Diabetic ketoacidosis[19] + + + + + + + Nl to ↓ Nl to ↑ ↑↑ Nl Nl to ↑ Nl + + Clinical + hyperglycemia + ketosis
  • Labs might show elevated K+ even in K+ depletion due to extravasation of intracellular K+ in exchanged with extracellular H+
Starvation[20] + + + + Nl Nl Nl Nl to ↓ Nl Nl Nl Nl Nl Nl + Clinical manifestation
Alcoholic ketoacidosis (Ethanol)[21] + + ± + ↓ ↑ + Agitated Nl to ↑ Nl to ↑ ↓ Nl ↑ Nl ↑↑ ↑↑ Nl + + Clinical manifestation + ketosis
Systemic Sepsis[22] + + + + + ↓ ↑ + Nl to ↓ Nl Nl Nl Nl Nl to ↑ Nl Nl Nl Clinical manifestation and lab finding
  • Not applicable
Ischemia[23] + + + + + ↓ ↑ Nl to ↓ Nl to ↑ Nl Nl Nl Nl Nl to ↑ Nl Nl Nl to ↑ Nl to ↑ Nl Clinical manifestation and lab finding
  • Not applicable
Lactic acidosis[24] + ± + + ↓ ↑ ± Agitated Nl to ↑ Nl Nl Nl Nl Nl Nl or ↑ Nl Clinical manifestation and lab finding
  • Not applicable
Renal Uremia[25] + + + + ↓ ↑ ± Nl to ↓ Nl Nl Nl Nl + Clinical manifestation and lab finding
Renal failure[26] + + + + Nl to ↓ Nl Nl Nl Renal function test
  • Not applicable
Renal tubular acidosis[27] Type I[28] + ± ± ↓ ↑ Nl Nl Nl Nl Nl Nl Nl Nl + Clinical manifestation and lab finding
Type II + ± ± ↓ ↑ Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Clinical manifestation and lab finding
  • Not applicable
Type IV + ± ± ± Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl + Clinical manifestation and lab finding
Category Disease ↑ acid
production
Loss of
bicarbonate
↓ renal acid
excretion
Fever N/V Diarrhea Dyspnea Toxic/ill BP Dehydration Level of consciousness HCO3 paCO2 O2 WBC Hb BS Cl K+ Na+ Ketones Lactic acid Serum AG Osmolar gap Bun Cr Urine pH Urine AG Urine ketone Gold standard diagnosis Other findings
Heart Heart failure[29] + + ± + + ↓ ↑ + ↓ ↑ Nl Nl Nl Nl Nl Nl Nl Nl Nl to ↑ Nl to ↑ Nl Clinical manifestation+ echocardiogram
Myocardial infarction[30] + + + + ↓ ↑ ↓ ↑ Nl to ↓ Nl to ↑ Nl Nl Nl Nl Nl Nl Nl to ↑ Nl to ↑ Nl Clinical manifestation + ECG
  • Not applicable
GI Diarrhea[31] + ± + + + + May be lethargic Nl Nl Nl Nl Nl Nl Nl Nl Nl Stool exam
  • Not applicable
Hyperalimentation[32] + + + Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Clinical manifestation
  • Not applicable
Liver failure[33] + + + + + Confused Nl Nl ↓ ↑ Nl Nl Nl Nl Nl Nl Nl Liver biopsy
  • Not applicable
Endocrine Hyperparathyroidism[34] + + + Nl + Confused Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl to ↑ Nl Nl PTH level
  • Not applicable
Addison’s disease[35] + + + + Irritable Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl Hormone level
Category Disease ↑ acid
production
Loss of
bicarbonate
↓ renal acid
excretion
Fever N/V Diarrhea Dyspnea Toxic/ill BP Dehydration Level of consciousness HCO3 paCO2 O2 WBC Hb BS Cl K+ Na+ Ketones Lactic acid Serum AG Osmolar gap Bun Cr Urine pH Urine AG Urine ketone Gold standard diagnosis Other findings

References

  1. Lim S (2007). “Metabolic acidosis”. Acta Med Indones. 39 (3): 145–50. PMID 17936961.
  2. Morris, C. G.; Low, J. (2008). “Metabolic acidosis in the critically ill: Part 1. Classification and pathophysiology”. Anaesthesia. 63 (3): 294–301. doi:10.1111/j.1365-2044.2007.05370.x. ISSN 0003-2409.
  3. Morris CG, Low J (April 2008). “Metabolic acidosis in the critically ill: part 2. Causes and treatment”. Anaesthesia. 63 (4): 396–411. doi:10.1111/j.1365-2044.2007.05371.x. PMID 18336491.
  4. Casaletto, Jennifer J. (2005). “Differential Diagnosis of Metabolic Acidosis”. Emergency Medicine Clinics of North America. 23 (3): 771–787. doi:10.1016/j.emc.2005.03.007. ISSN 0733-8627.
  5. Brubaker RH, Meseeha M. High Anion Gap Metabolic Acidosis. [Updated 2017 Oct 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448090/
  6. Kraut JA, Xing SX (September 2011). “Approach to the evaluation of a patient with an increased serum osmolal gap and high-anion-gap metabolic acidosis”. Am. J. Kidney Dis. 58 (3): 480–4. doi:10.1053/j.ajkd.2011.05.018. PMID 21794966.
  7. Pham, Amy Quynh Trang; Xu, Li Hao Richie; Moe, Orson W. (2015). “Drug-Induced Metabolic Acidosis”. F1000Research. doi:10.12688/f1000research.7006.1. ISSN 2046-1402.
  8. Zehtabchi S, Sinert R, Baron BJ, Paladino L, Yadav K (2005). “Does ethanol explain the acidosis commonly seen in ethanol-intoxicated patients?”. Clin Toxicol (Phila). 43 (3): 161–6. PMID 15902789.
  9. Roberts, Darren M.; Yates, Christopher; Megarbane, Bruno; Winchester, James F.; Maclaren, Robert; Gosselin, Sophie; Nolin, Thomas D.; Lavergne, Valéry; Hoffman, Robert S.; Ghannoum, Marc (2015). “Recommendations for the Role of Extracorporeal Treatments in the Management of Acute Methanol Poisoning”. Critical Care Medicine. 43 (2): 461–472. doi:10.1097/CCM.0000000000000708. ISSN 0090-3493.
  10. Ashurst JV, Nappe TM. Toxicity, Isopropanol. [Updated 2018 Mar 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493181/
  11. Camara-Lemarroy, Carlos Rodrigo; Rodríguez-Gutiérrez, René; Monreal-Robles, Roberto; González-González, José Gerardo (2015). “Acute toluene intoxication–clinical presentation, management and prognosis: a prospective observational study”. BMC Emergency Medicine. 15 (1). doi:10.1186/s12873-015-0039-0. ISSN 1471-227X.
  12. Wright, Dallas; Sop, Jessica (2015). “Normal anion gap salicylate poisoning”. The American Journal of Emergency Medicine. 33 (11): 1714.e3–1714.e4. doi:10.1016/j.ajem.2015.03.042. ISSN 0735-6757.
  13. Galiero, Francesca; Consani, Giovanni; Biancofiore, Gianni; Ruschi, Stefano; Forfori, Francesco (2018). “Metformin intoxication: Vasopressin’s key role in the management of severe lactic acidosis”. The American Journal of Emergency Medicine. 36 (2): 341.e5–341.e6. doi:10.1016/j.ajem.2017.10.057. ISSN 0735-6757.
  14. Watkins RC, Hambrick EL, Benjamin G, Chavda SN (January 1990). “Isoniazid toxicity presenting as seizures and metabolic acidosis”. J Natl Med Assoc. 82 (1): 57, 62, 64. PMC 2625939. PMID 2304098.
  15. Teppema, Luc J.; Balanos, George M.; Steinback, Craig D.; Brown, Allison D.; Foster, Glen E.; Duff, Henry J.; Leigh, Richard; Poulin, Marc J. (2007). “Effects of Acetazolamide on Ventilatory, Cerebrovascular, and Pulmonary Vascular Responses to Hypoxia”. American Journal of Respiratory and Critical Care Medicine. 175 (3): 277–281. doi:10.1164/rccm.200608-1199OC. ISSN 1073-449X.
  16. Bates, D. W.; Su, L.; Yu, D. T.; Chertow, G. M.; Seger, D. L.; Gomes, D. R. J.; Dasbach, E. J.; Platt, R. (2001). “Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy”. Clinical Infectious Diseases. 32 (5): 686–693. doi:10.1086/319211. ISSN 1058-4838.
  17. Piantadosi CA (June 1999). “Diagnosis and treatment of carbon monoxide poisoning”. Respir Care Clin N Am. 5 (2): 183–202. PMID 10333448.
  18. Baud FJ, Borron SW, Mégarbane B, Trout H, Lapostolle F, Vicaut E, Debray M, Bismuth C (September 2002). “Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning”. Crit. Care Med. 30 (9): 2044–50. doi:10.1097/01.CCM.0000026325.65944.7D. PMID 12352039.
  19. Wolfsdorf, Joseph I; Allgrove, Jeremy; Craig, Maria E; Edge, Julie; Glaser, Nicole; Jain, Vandana; Lee, Warren WR; Mungai, Lucy NW; Rosenbloom, Arlan L; Sperling, Mark A; Hanas, Ragnar (2014). “Diabetic ketoacidosis and hyperglycemic hyperosmolar state”. Pediatric Diabetes. 15 (S20): 154–179. doi:10.1111/pedi.12165. ISSN 1399-543X.
  20. Mostert M, Bonavia A (October 2016). “Starvation Ketoacidosis as a Cause of Unexplained Metabolic Acidosis in the Perioperative Period”. Am J Case Rep. 17: 755–758. PMC 5070574. PMID 27752032.
  21. Howard RD, Bokhari S. PMID 28613672. Vancouver style error: initials (help); Missing or empty |title= (help)
  22. Ganesh K, Sharma RN, Varghese J, Pillai MG (2016). “A profile of metabolic acidosis in patients with sepsis in an Intensive Care Unit setting”. Int J Crit Illn Inj Sci. 6 (4): 178–181. doi:10.4103/2229-5151.195417. PMC 5225760. PMID 28149822.
  23. Kimmoun, Antoine; Novy, Emmanuel; Auchet, Thomas; Ducrocq, Nicolas; Levy, Bruno (2015). “Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside”. Critical Care. 19 (1). doi:10.1186/s13054-015-0896-7. ISSN 1364-8535.
  24. Kraut, Jeffrey A.; Ingelfinger, Julie R.; Madias, Nicolaos E. (2014). “Lactic Acidosis”. New England Journal of Medicine. 371 (24): 2309–2319. doi:10.1056/NEJMra1309483. ISSN 0028-4793.
  25. Brown, Denver; Melamed, Michal L. (2018). “New Frontiers in Treating Uremic Metabolic Acidosis”. Clinical Journal of the American Society of Nephrology. 13 (1): 4–5. doi:10.2215/CJN.11771017. ISSN 1555-9041.
  26. Kraut, Jeffrey A.; Madias, Nicolaos E. (2016). “Metabolic Acidosis of CKD: An Update”. American Journal of Kidney Diseases. 67 (2): 307–317. doi:10.1053/j.ajkd.2015.08.028. ISSN 0272-6386.
  27. Gil-Peña, Helena; Mejía, Natalia; Santos, Fernando (2014). “Renal Tubular Acidosis”. The Journal of Pediatrics. 164 (4): 691–698.e1. doi:10.1016/j.jpeds.2013.10.085. ISSN 0022-3476.
  28. Hemstreet, Brian A (2004). “Antimicrobial-Associated Renal Tubular Acidosis”. Annals of Pharmacotherapy. 38 (6): 1031–1038. doi:10.1345/aph.1D573. ISSN 1060-0280.
  29. Park, Jin Joo; Choi, Dong-Ju; Yoon, Chang-Hwan; Oh, Il-Young; Lee, Ju Hyun; Ahn, Soyeon; Yoo, Byung-Su; Kang, Seok-Min; Kim, Jae-Joong; Baek, Sang-Hong; Cho, Myeong-Chan; Jeon, Eun-Seok; Chae, Shung Chull; Ryu, Kyu-Hyung; Oh, Byung-Hee (2015). “The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry”. European Journal of Heart Failure. 17 (6): 601–611. doi:10.1002/ejhf.276. ISSN 1388-9842.
  30. Mann, Sarah; Bajulaiye, Akinyemi; Sturgeon, Kathleen; Sabri, Abdelkarim; Muthukumaran, Geetha; Libonati, Joseph R. (2014). “Effects of acute angiotensin II on ischemia reperfusion injury following myocardial infarction”. Journal of the Renin-Angiotensin-Aldosterone System. 16 (1): 13–22. doi:10.1177/1470320314554963. ISSN 1470-3203.
  31. Guerrant, R. L.; Van Gilder, T.; Steiner, T. S.; Thielman, N. M.; Slutsker, L.; Tauxe, R. V.; Hennessy, T.; Griffin, P. M.; DuPont, H.; Bradley Sack, R.; Tarr, P.; Neill, M.; Nachamkin, I.; Reller, L. B.; Osterholm, M. T.; Bennish, M. L.; Pickering, L. K. (2001). “Practice Guidelines for the Management of Infectious Diarrhea”. Clinical Infectious Diseases. 32 (3): 331–351. doi:10.1086/318514. ISSN 1058-4838.
  32. Erlingsson, Styrbjörn; Herard, Sebastian; Dahlqvist Leinhard, Olof; Lindström, Torbjörb; Länne, Toste; Borga, Magnus; Nystrom, Fredrik H. (2009). “Men develop more intraabdominal obesity and signs of the metabolic syndrome after hyperalimentation than women”. Metabolism. 58 (7): 995–1001. doi:10.1016/j.metabol.2009.02.028. ISSN 0026-0495.
  33. Lange, Christian M.; Bojunga, Jörg; Hofmann, Wolf Peter; Wunder, Katrin; Mihm, Ulrike; Zeuzem, Stefan; Sarrazin, Christoph (2009). “Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function”. Hepatology. 50 (6): 2001–2006. doi:10.1002/hep.23346. ISSN 0270-9139.
  34. Bilezikian, John P.; Potts, John T.; Fuleihan, Ghada El-Hajj; Kleerekoper, Michael; Neer, Robert; Peacock, Munro; Rastad, Jonas; Silverberg, Shonni J.; Udelsman, Robert; Wells, Samuel A. (2002). “Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century”. The Journal of Clinical Endocrinology & Metabolism. 87 (12): 5353–5361. doi:10.1210/jc.2002-021370. ISSN 0021-972X.
  35. Ten, Svetlana; New, Maria; Maclaren, Noel (2001). “Addison’s Disease 2001”. The Journal of Clinical Endocrinology & Metabolism. 86 (7): 2909–2922. doi:10.1210/jcem.86.7.7636. ISSN 0021-972X.
Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Most studies only had serum bicarbonate concentrations available and defined metabolic acidosis using the bicarbonate levels as standard. At time no meaningful contribution of respiratory system was considered in metabolic acidosis. Most epidemiologic studies have measured serum bicarbonate using an autoanalyzer using either an electrode-based or enzymatic method. The specimens are often shipped to a central laboratory by air to minimize assay variability. Scientists found that there was a difference in the bicarbonate levels between measurement of blood at a local laboratory and those shipped to a central laboratory. Bicarbonate measured at a central laboratory was always lower than that measured at a local laboratory. Then it was hypothesized that it is due to potential gas leak from a different atmospheric pressure during air travel. The time that samples were exposed to air in commercial laboratories also contributed to the variability in bicarbonate values. There are few studies that measured arterialized venous blood gas. For sampling, The patient’s hand or wrist have been placed in a warmer set to 42°C for a minimum of 15 minutes for Arterialized venous blood gas samples. As it provides a full assessment of acid-base status and is usually measured at the point of care, thus eliminating the errors that might have occurred during specimen transport. Due to cumbersome method of obtaining arterial blood gas sample, arterialized venous blood gas is often used for research purpose.[1][2][3]



References

  1. Kirschbaum B (2000). “Spurious metabolic acidosis in hemodialysis patients”. Am J Kidney Dis. 35 (6): 1068–71. doi:10.1016/s0272-6386(00)70041-2. PMID 10845818.
  2. Zazra JJ, Jani CM, Rosenblum S (2001). “Are the results of carbon dioxide analysis affected by shipping blood samples?”. Am J Kidney Dis. 37 (5): 1105–6. doi:10.1016/s0272-6386(05)80031-9. PMID 11325696.
  3. Schmoldt A, Benthe HF, Haberland G (1975). “Digitoxin metabolism by rat liver microsomes”. Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.1053/j.ackd.2017.08.003 Check |pmid= value (help).

Template:WH Template:WS

Risk Factors
Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Prognosis and recovery of Metabolic Acidosis is dependent on the causative factor. Appropriate and timely treatment takes time but help in recovery. Some people totally recover from Metabolic Acidosis whereas others may develop


COMPLICATIONS FROM USE OF BICARBONATES:

Caution with bicarbonate therapy is indicated because of its potential complications, including the following:


PROGNOSIS:

The prognosis is directly related to the underlying etiology and the ability to treat or correct that particular disorder.

  • A study in 2016 indicated that in patients undergoing renal replacement therapy, an association exists between uncorrected severe metabolic acidosis (serum bicarbonate concentrations of below 20 mmol/L) and a 10-year risk for coronary heart disease of over 20%, as well as a high overall mortality rate.[1]
  • A study in 2017 indicated that a high rate of metabolic acidosis occurs in kidney transplant recipients; a low serum total CO2 concentration (< 22 mmol/L) was found in about 30-70% of such patients with an estimated glomerular filtration rate of under 30 mL/min per 1.73 m2. The study also found evidence that metabolic acidosis may increase the likelihood of mortality in kidney transplant recipients[2] and graft failure.
  • In a study of emergency department patients with acute kidney injury, metabolic acidosis is independently associated with mortality, along with sex, age over 60 years, blood urea nitrogen (BUN) concentration, hyperkalemia, cause of renal failure, and type of renal failure. [3]

References

  1. Kahn T, Bosch J, Levitt MF, Goldstein MH (1975). “Effect of sodium nitrate loading on electrolyte transport by the renal tubule”. Am J Physiol. 229 (3): 746–53. doi:10.1152/ajplegacy.1975.229.3.746. PMID 4(4):170-177 (ISSN: 2450-131X) 2016; 4(4):170-177 (ISSN: 2450-131X) Check |pmid= value (help).
  2. Ehrhart IC, Parker PE, Weidner WJ, Dabney JM, Scott JB, Haddy FJ (1975). “Coronary vascular and myocardial responses to carotid body stimulation in the dog”. Am J Physiol. 229 (3): 754–60. doi:10.1152/ajplegacy.1975.229.3.754. PMID 28(6):1886-1897 2017; 28(6):1886-1897 Check |pmid= value (help).
  3. Safari S, Hashemi B, Forouzanfar MM, Shahhoseini M, Heidari M (2018). “Epidemiology and Outcome of Patients with Acute Kidney Injury in Emergency Department; a Cross-Sectional Study”. Emerg (Tehran). 6 (1): e30. PMC 6036528. PMID 30009232.

Template:WH Template:WS

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH